Boston Scientific BSX shares are trading lower by $0.80 at $18 in Wednesday's session. Traders are attributing the decline to a Wells Fargo note insinuating insurance coverage for the Watchman product may change.
Interestingly, the issue sold off in after-hours trading on Tuesday from its close of $18.80 to $18.20 by the 8:00 PM close. That was well ahead of the comments from the Wells Fargo analyst.
In today's session, it has found support one penny ahead of its October 29 low ($17.95), but has not able to rebound any higher than $18.27.
Joel Elconin is the co-host of Benzinga;s #PreMarket Prep, a daily trading idea radio show.
Do you like this article? Do you have suggestions for improvement? Please email feedback@benzinga.com.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in